MENU
BCDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioCardia (BCDA) Ownership - Who owns BioCardia?
Profile
Industry
N/A
Address
320 Soquel Way
Phone
+1 650 226-0120
Employees
20
Web
https://www.biocardia.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.3M
P/E Ratio
N/A
Total Cash
1.1M
Projected Growth
N/A
Total Debt
1.23M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.31
Total Debt/Equity
N/A
Revenue/Share
0.26 USD as % of share price
Fundamentals
BCDA
Capitalization
10.3M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
1.1M
Total Cash/Share
0.31
Total Debt
1.23M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.26%
Revenue
N/A
ROE
N/A
Book Value
-2.28M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
27K
Current Ratio
0.31
Current Revenue Per Employee
2750.00
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
3.5M
Total Liabilities
4.95M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-71.193
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage regenerative medicine company, which develops novel therapeutics for cardiovascular diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
320 Soquel Way
Phone
+1 650 226-0120
Employees
20
Web
https://www.biocardia.com